Koate is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Koate is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameKoate
Authorized genericantihemophilic factor (human)
Regular genericantihemophilic factor (human)
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Koate?
The original
–
–

Brand nameThe maker’s card

KOĀTE Copay Assistance Program

Savings card from Kedrion Biopharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · up to $15,000 off a year

Sign up on koate.medmonk.com 

Or call 1-888-262-8040.

In the maker’s words

“Eligible patients can receive up to $15,000 over 12 months to cover the deductible, copay, and/or coinsurance for KOĀTE.”

From the maker’s offer on koate.medmonk.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Koate itself, from the same company, sold without the brand name, and usually for less. For now Koate is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Koate is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

KOĀTE is a human plasma-derived antihemophilic factor indicated for the control and prevention of bleeding episodes or in order to perform emergency and elective surgery in patients with hemophilia A (hereditary Factor VIII deficiency ).

Limitation of Use KOĀTE is not indicated for the treatment of von Willebrand disease.

Source: the FDA label for Koate (KEDRION BIOPHARMA, INC.), December 13, 2023. Full label on DailyMed 

Good to know